Drug recall · February 22, 2017
Venlafaxine Hydrochloride extended release capsules recall
Why: Failed Tablet/Capsule Specifications: Some bottles contain punctured, and/or clumped/melted capsules.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Venlafaxine Hydrochloride extended release capsules, 37.5 mg, 30-count bottles, Rx Only, Manufactured for: Aurobindo Pharma USA, Inc. 2400 Route 130 North, Dayton, NJ 08810 Manufactured by: Aurobindo Pharma Limited Hyderabad-500 072 India, NDC 65862-527-30
- Lots / codes
Lot #: VI3716010-A, Exp. 04/2018
- Quantity
- 47,040 bottles
- Company
- Aurobindo Pharma USA Inc, Plainsboro, NJ
- Distribution
- Nationwide in the US
- Initiated
- December 22, 2016 · Voluntary: Firm initiated
- Classified
- February 13, 2017
- Reported
- February 22, 2017
- Ended
- March 19, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Venlafaxine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.